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A B S T R A C T   
In this study, we investigated the role of cardiomyocyte (CM) and endothelial cell (EC) specific interactions with 
collagen in the assembly of an operational myocardium in vitro. Engineered cardiac patches represent valuable 
tools for myocardial repair following infarction and are generally constituted of a suitable biomaterial populated 
by CMs and supportive cell types. Among those, ECs are required for tissue vascularization and positively 
modulate CM function. To direct the function of human embryonic stem cell (hESC)-derived CM and EC seeded 
on biomaterials, we replicated cell-collagen interactions, which regulate cellular behaviour in the native 
myocardium, using triple-helical peptides (THPs) that are ligands for collagen-binding proteins. THPs enhanced 
proliferation and activity of CMs and ECs separately and in co-culture, drove CM maturation and enabled co-
ordinated cellular contraction on collagen films. These results highlight the importance of collagen interactions 
on cellular response and establish THP-functionalized biomaterials as novel tools to produce engineered cardiac 
tissues.   
1. Introduction 
Recovery of cardiomyocyte (CM) loss represents the main challenge 
in patients suffering from ischemic heart failure. Current therapies fail to 
address this loss by means other than cardiac transplantation. Pluripo-
tent stem cell-derived CMs have emerged as new tools to treat infarcted 
hearts [1,2]. CMs can be injected and successfully engraft, align and 
couple with the host myocardium and improve cardiac function [3]. 
However, the vast majority of cells die upon injection, in part due to 
early washout or anoikis. Delivering CM in the form of a suitable cardiac 
patch may circumvent these limitations. Long term patch survival and 
integration with the host tissue vasculature are key issues to address. 
Incorporating endothelial cells (ECs) in the patch therefore represents a 
promising solution. Several groups have developed engineered heart 
tissues [4–8]. However, despite recent advances, significant issues still 
need to be addressed such as the optimal cell composition, matrix 
components and mechanical properties needed to recapitulate the 
myocardium. In particular, cell interaction with the extra-cellular ma-
trix (ECM) especially collagen, the main constituent of the ECM, has 
been generally overlooked despite its potential to direct cell fate and 
function [9–11]. 
Here, we propose to investigate the role of CM- and EC-specific in-
teractions with collagen in the assembly of engineered tissues. Collagen 
is widely used to produce biomaterial scaffolds [12,13]. Collagen 
crosslinking naturally occurs to provide collagen fibrils with biome-
chanical capabilities and adequate resistance. In tissue engineering, this 
crosslinking is often substituted by 1-ethyl-3-(3-dimethylamino-propyl) 
carbodiimide (EDC) and N-hydroxysuccinimide (NHS) treatment [14] 
leading to stiff materials with long term structural integrity. However, 
EDC/NHS treatment recruits and consumes aspartate, glutamate and 
lysine residues from the collagen sequence that would otherwise be 
involved in cellular interaction [15,16]. EDC/NHS crosslinked collagen 
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biomaterials thus reproduce the physical characteristic of the myocar-
dium but are biologically inert to many cell types. 
In this study, cell-collagen interactions in crosslinked collagen ma-
terials were re-instated by grafting specific triple-helical peptides 
(THPs). THPs are composed of three peptide strands, each constituted of 
a series of GXX’ triplets. They adopt a triple helix conformation with a 
one amino acid stagger mimicking the natural structure of collagen. In 
particular, THPs containing the GFOGER or GLOGEN motif are ligands 
for collagen-binding integrins α1β1, α2β1, α10β1 and α11β1 [17,18]. 
GPRGQOGVMGFO and its derivative GPRGQOGVNleGFO (referred to as 
VWFIIINle in the literature) are sequences targeting the discoidin domain 
receptors (DDRs) 1 [19] and 2 [20], the von Willebrand Factor (VWF) 
[21] and the Secreted Protein Acidic and Rich in Cysteine (SPARC) [22, 
23]. THPs containing GFOGER or GPRGQOGVNleGFO sequences 
restored and enhanced non-cardiac cell function on 2D collagen film 
models in our previous proof-of-concept work [24,25]. 
We have thus designed an engineered tissue composed of collagen 
films functionalized with THPs and populated with human embryonic 
stem cell (hESC)-derived CMs and ECs separately or in co-culture. We 
identified the correct set of THPs that enabled optimal cell attachment, 
survival, proliferation and function. Overall, investigating cellular 
response to THPs gave us insight into the influence of collagen-binding 
protein on cell function and could represent a new tool to generate next 
generation engineered myocardial patches. Our methodology can be 
extended to other relevant cell types, such as epicardial cells, cardiac 
fibroblasts or smooth muscle cells [26]. THP-functionalized crosslinked 
collagen films could provide a convenient engineered heart tissue for the 
in vitro study of cardiac pathologies. Furthermore, this technology could 
be transposed to three-dimensional scaffolds for the manufacturing of 
patches for damaged heart repair. 
2. Results 
2.1. Collagen film functionalization with THPs 
To predict possible THP interactions with ECs and CMs, the expres-
sion of mRNA for collagen-binding proteins were assessed by RT-qPCR 
(Fig. 1, A-B). β1 integrin subunit was expressed at high levels in both 
cell types. ECs express predominantly the α1 integrin subunit (0.14 ±
0.02), relatively small amounts for α2 (0.02 ± 0.006) and no α10 and 
α11. CMs also expressed α1 the most (0.32 ± 0.05), followed by α10 
(0.087 ± 0.03), α2 (0.02 ± 0.002) and α11 (0.01 ± 0.001). Integrin 
expression at protein level was also assessed by flow cytometry. Mean 
fluorescence intensity (MFI) quantification showed a similar trend to the 
mRNA data. However, it revealed that the differences in protein 
expression between collagen-binding integrins are not as pronounced, 
with a lower but non-negligible expression of integrin α2 at the cell 
surface both of endothelial cells and cardiomyocytes (Supporting in-
formation 1). GFOGER binds preferentially, but not exclusively, to α2β1 
and α11β1 and GLOGEN binds preferentially to α1β1 and α10β1 (Sup-
porting information 2) [17,18]. Taking into consideration both the 
protein and mRNA expression data, we expect GLOGEN to contribute 
more efficiently than GFOGER to cell affinity for the substrate. 
Among the non-integrin collagen receptors, DDR1, DDR2, vWF and 
Fig. 1. Crosslinked collagen films are functionalized with THPs targeting collagen-binding proteins and seeded with endothelial cells and cardiomyocytes. A) and B) 
Relative mRNA expression of genes coding for collagen-binding integrins subunits (α1, α2, α10, α11 and β1), DDR1, DDR2, SPARC and vWF was examined in 
endothelial cells (A) and cardiomyocytes (B). mRNA from three independent cell batches of hESC-derived ECs and CMs ready for seeding upon collagen films was 
isolated, purified and transcribed into complementary cDNA. cDNA was amplified and quantified by qPCR (compared to a house-keeping gene GAPDH for integrin 
subunits and HPRT1 for DDR1, DDR2, SPARC and vWF); graphs show mean ± s.e.m. Integrin α subunits mRNA expression ranking was α1 > α2 > α10 and α11 for 
ECs and α1 > α10 > α2 and α11 for CMs. VWFIIINle-binding proteins mRNA expression ranking was SPARC ≫ vWF > DDR1 and DDR2 for ECs, and SPARC > DDR1 >
DDR2 and vWF for CMs. C) Synthetic pathway of collagen film functionalization with THPs. Peptides that contain the active sequences GFOGER (targeting pref-
erentially α2β1 and α11β1 integrins), GLOGEN (targeting preferentially α1β1 and α10β1 integrins) or GPRGQOGVNleGFO (targeting DDR1, DDR2, vWF, SPARC) are 
assembled on solid support by Fmoc/tBu strategy, end-stapled using the GFGEEG hexapeptide, reacted with NHS-Diazirine and removed from the support to yield 
photoreactive THPs. Photoreactive THPs were incubated on crosslinked collagen films and covalently attached to the collagen backbone upon UV treatment. Non- 
crosslinked films, crosslinked films with no peptide or films functionalized with THPs are then populated with hESC-derived ECs and CMs. 
M. Colzani et al.                                                                                                                                                                                                                                
Biomaterials 269 (2021) 120612
3
SPARC bind to the VWFIIINle motif [20–22]. Both cell types expressed 
considerably higher levels of SPARC (176.10 ± 37.39 for ECs and 30.78 
± 7.50 for CMs) relative to other VWFIIINle-binding proteins. vWF (5.08 
± 1.73) was also detected in ECs and mRNA for DDR1 was detected in 
CMs (7.37 ± 1.81). DDR2 (0.48 ± 0.26 for ECs and 0.99 ± 0.47 for CMs), 
DDR1 in ECs (0.97 ± 0.38) and vWF in CMs (0.004 ± 0.01) were 
expressed in lesser amounts (Fig. 1, A-B). We therefore predicted that 
VWFIIINle will mainly interact with SPARC secreted by ECs and CMs. 
Nevertheless, VWFIIINle may also influence cell response by interacting 
with vWF secreted by ECs and through DDR1 in CMs. Overall these re-
sults prompted us to generate collagen films functionalized with 
GFOGER, GLOGEN, VWFIIINle, GFOGER + VWFIIINle, or GLOGEN +
VWFIIINle as described previously [24,25](Fig. 1, C). 
2.2. ESC-derived EC behaviour on collagen films 
ECs were seeded on crosslinked collagen films (noted XL in figures) 
without peptides or functionalized with GFOGER, GLOGEN or VWFIIINle 
as well as on non-crosslinked films (noted Non-XL in figures). Surpris-
ingly, without peptides, ECs adhere to crosslinked films in a magnesium- 
dependent manner, indicating integrin dependence (Supporting infor-
mation 3). While EDC/NHS treatment affects integrin recognition, 
Fig. 2. Endothelial cell cultures on crosslinked collagen films without peptide, functionalized with GFOGER, with GLOGEN, with VWFIIINle and with 
GFOGER þ VWFIIINle, or non-crosslinked films. A) EC spreading. After 45 min at 37 ◦C with 5% CO2, hESC-derived ECs were fixed and stained with Rhodamine- 
Phalloidin. Representative fields of view for GFOGER and GLOGEN are shown. Mean cell area was calculated from 10 randomly selected fields of view per conditions 
in three independent repeats (n = 3) and plotted as mean ± s.e.m. THP functionalization consistently increased mean cell surface area (one-way ANOVA, p < 0.001). 
Columns were compared to crosslinked films with no peptides using Dunnett’s post-hoc test. B) EC proliferation. hESC-derived ECs were cultured for 24 h at 37 ◦C 
with 5% CO2. EdU was introduced in the media and cells were left for 2h at 37 ◦C with 5% CO2. Cells were fixed, nuclei were stained with Hoechst 33342 and EdU 
was stained with Alexa Fluor-488. The ratio of cells with EdU-Alexa488 over the total number of cells was calculated from 10 randomly selected fields of view per 
conditions in three independent repeats (n = 3) and plotted as mean ± s.e.m. THP functionalization consistently increased the percentage of proliferating ECs after 
24h (one-way ANOVA, p < 0.01). Columns were compared to crosslinked films with no peptides using Dunnett’s post-hoc test. C) EC LDL uptake. hESC-derived ECs 
were cultured in cell culture media containing Ac-LDL-Dil for 24 h at 37 ◦C with 5% CO2, fixed and stained with Hoechst 33342. Representative fields of view are 
shown. Mean Dil fluorescence intensity per cell was measured in 10 randomly selected fields of view per conditions in four independent repeats (n = 4) and plotted as 
mean ± s.e.m. THP functionalization consistently increased the uptake of acetylated LDL by ECs (one-way ANOVA, p < 0.01). Columns were compared to crosslinked 
films with no peptides using Dunnett’s post-hoc test. 
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binding motifs may not be fully ablated and were sufficient to support 
initial cell adhesion. Significant differences, however, were observed in 
cell spreading (Supporting information 4). Peptides grafted on cross-
linked films increased cell size in all conditions (1875 ± 226.1 μm,2 p <
0.01 for GFOGER, 1991 ± 292.3 μm,2 p < 0.01 for GLOGEN, 2065 ±
124.9 μm,2 p < 0.001 for VWFIIINle, 1855 ± 216.4 μm,2 p < 0.01 for 
GFOGER + VWFIIINle and 2139 ± 222.4 μm,2 p < 0.001 for GLOGEN +
VWFIIINle) when compared to the crosslinked collagen films without 
peptide (1110 ± 204 μm2) (Fig. 2, A). Unexpectedly, ECs seeded on non- 
crosslinked films displayed a similar morphology as on crosslinked films 
(1046 ± 87.39 μm2). 
Next, EC proliferation 24h after seeding was investigated. 14.24 ±
0.93% of ECs were EdU positive on crosslinked films without peptide. 
This percentage rose to 24.88 ± 1.11% with GFOGER (p < 0.05), 28.96 
± 1.32% with GLOGEN (p < 0.001), and 21.49 ± 2.95% with VWFIIINle 
(not significant). Combining VWFIIINle with GFOGER (23.99 ± 2.60%, p 
< 0.05) and GLOGEN (27.68 ± 3.72%, p < 0.01) also led to an increase 
in proliferation compared to non-functionalized crosslinked films, but 
not compared to crosslinked films grafted with THPs individually 
(Fig. 2, B; supporting information 5). 
EC function was investigated via uptake of acetylated low-density 
lipoprotein (Ac-LDL) (Fig. 2, C). Ac-LDL-Dil was detected around the 
cell nucleus and the levels Ac-LDL-Dil fluorescence per cell rose from 
7395 ± 2248 AU on 100% crosslinked films to 35841 ± 11241 AU (not 
significant), 39161 ± 11326 AU (p < 0.05) and 38064 ± 11670 AU (p <
0.05) with GFOGER, GLOGEN and VWFIIINle respectively. The combi-
nation of VWFIIINle and integrin-binding peptides resulted in a more 
significant increase in Ac-LDL-Dil uptake (50942 ± 13433 AU, p < 0.01 
with GFOGER and 52726 ± 19337 AU, p < 0.01 with GLOGEN). On non- 
crosslinked collagen films Ac-LDL-Dil was detected (37125 ± 17003 AU 
per cell), but rarely accumulated in the cytoplasm. Taken together these 
results indicated that GFOGER, GLOGEN and VWFIIINle facilitate the 
cellular response of ECs. 
2.3. ESC-derived CMs behaviour on collagen films 
CMs were cultured on functionalized collagen films and their 
viability was assessed by PrestoBlue® at day 5 (Fig. 3, A). Viability was 
comparable between non-crosslinked films and crosslinked films with 
GFOGER or with GLOGEN (396197 ± 10993.65, 472769.7 ± 4505.828 
and 408811 ± 6063.209 AU respectively). Significantly lower values 
were obtained on crosslinked films without peptides or with VWFIIINle 
(189906 ± 1564.068 and 254070.7 ± 2735.761 respectively) (Fig. 3. 
Therefore, CMs viability is significantly reduced by the EDC/NHS 
treatment and can be fully restored by grafting THP ligands for the 
collagen-binding integrins, whereas VWFIIINle-mediated signalling only 
Fig. 3. Cardiomyocyte cultures on crosslinked collagen films without peptide, functionalized with GFOGER, with GLOGEN and with VWFIIINle, or non- 
crosslinked films. A) CM viability. After 5 days at 37 ◦C with 5% CO2, PrestoBlue® with and without 5 mM EDTA was added to cell culture media, fluores-
cence at 560 nm was measured in three independent repeats (n = 3) and plotted as mean ± s.e.m. GFOGER and GLOGEN significantly restored CM viability abolished 
by EDC/NHS treatment after 5 days (one-way ANOVA, p < 0.001). Columns were compared to crosslinked films with no peptides using Dunnett’s post-hoc test. B) 
CM immunocytochemistry. hESC-derived CMs were cultured for 5 days at 37 ◦C with 5% CO2 and stained with Troponin T-Alexa Fluor-488, Connexin-43-Alexa 
Fluor-568 and DAPI. Representative fields of view are shown. Panels from left to right show Troponin T, Connexin-43 and DAPI staining, and merge. CM cultured on 
crosslinked films without peptide or with VWFIIINle formed clumps, whereas CMs cultured on crosslinked films with GFOGER or GLOGEN, or on non-crosslinked films 
formed monolayers with intercellular punctate gap junctions. Scale bar 100 μm. C) CM proliferation. hESC-derived CMs were cultured for 3 days at 37 ◦C with 5% 
CO2. BrdU was introduced in the media and cells were left for 12h further at 37 ◦C with 5% CO2. Cells were fixed and nuclei were stained with DAPI and internalized 
BrdU with Alexa-568. The ratio of cell nuclei with BrdU over the total number of nuclei was calculated from 5 randomly selected fields of view per conditions in three 
independent repeats (n = 3) and plotted as mean ± s.e.m. GFOGER and GLOGEN significantly increased the percentage of proliferating CMs after 4 days (one-way 
ANOVA, p < 0.01). Columns were compared to crosslinked films with no peptides using Dunnett’s post-hoc test. 
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has a limited effect. The addition of EDTA resulted in a dramatic drop in 
fluorescence on all crosslinked films (between 85960.66 ± 2161.564 
and 130479.7 ± 1785.082 AU and 233853.7 ± 1640.333 AU on non- 
crosslinked films). Fluorescence was not completely ablated in the 
presence of EDTA indicating a potential role for non-integrin collagen 
receptors in CMs adhesion. However, the remaining cells were lost 
during the subsequent staining procedure suggesting only a loose 
attachment via non-integrin mechanisms. 
Troponin-T staining showed that CMs formed a monolayer and 
Connexin-43 staining revealed punctate intercellular communications 
Fig. 4. Relative mRNA expression of cardiac genes in CMs cultured alone or with ECs. mRNA from three independent batches (n = 3) of CM only or CM:EC 
cultures after 5 days was isolated, purified and transcribed into complementary cDNA. cDNA was amplified and quantified by qPCR compared to a GAPDH house- 
keeping gene (graphs show mean ± s.e.m.). MYL7, MYH6, MYH7, TNNI1, TNNI3, RYR2 and SCN5a were upregulated with GFOGER, GLOGEN, GFOGER + VWFIIINle 
and GLOGEN + VWFIIINle for CM only cultures (one-way ANOVA, p < 0.0001). All genes were strongly upregulated with all sets of THPs for EC:CM co-cultures (one- 
way ANOVA, p < 0.0001). Adult isoform/foetal isoform gene expression with GFOGER, GLOGEN, VWFIIINle, GFOGER + VWFIIINle, GLOGEN + VWFIIINle and non- 
crosslinked films was calculated for MYL2/MYL7, MYH7/MYH6 and TNNI3/TNNI1. CM only cultures resulted in higher MYL2/MYL7, while CM:EC co-cultures 
resulted in higher MYH7/MYH6 and TNNI3/TNNI1 ratios (one-way ANOVA, p < 0.0001). Overall, THPs in CM:EC co-cultures guided most advanced CM maturation. 
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on films non-crosslinked or crosslinked and functionalized with GFO-
GER or GLOGEN. In contrast, cells clustered into clumps on crosslinked 
films with no peptide or with VWFIIINle, with diffuse Connexin-43 
staining and some Troponin-T negative cells, implying possible CM 
dedifferentiation (Fig. 3, B). 
Further, CM proliferation 4 days after seeding was investigated 
(Supporting information 6). Collagen film crosslinking almost entirely 
ablated cell proliferation (from 13.79 ± 2.136% on non-crosslinked 
films to 2.606 ± 1.418% on crosslinked films). THP ligands re- 
established the proportion of proliferating cells back to 8.767 ±
2.171% with VWFIIINle (not significant), 10.62 ± 1.295% with GFOGER 
(p < 0.05) and 13.70 ± 0.9436% with GLOGEN (p < 0.01). GLOGEN was 
more efficient than GFOGER in restoring cell proliferation, which in turn 
was more efficient than VWFIIINle (Fig. 3, C). 
We also examined expression of genes associated with sarcomeric 
assembly (Fig. 4). In addition to the conditions above, CMs were also 
seeded on films functionalized with GFOGER + VWFIIINle and GLOGEN 
+ VWFIIINle. Except MYL2, the expression of which remained consistent 
across all conditions, all genes were more abundantly expressed on 
crosslinked films with GFOGER and GLOGEN compared to without 
peptides or with VWFIIINle (479-, 234-, 947-, 211- and 2.5-fold increases 
in average for MYL7, MYH6, MYH7, TNNI1 and TNNI3 respectively). 
MYH7/MYH6, MYL2/MYL7 and TNNI3/TNNI1 ratios were also calcu-
lated as indicators of CM maturation. Since sarcomeric genes (besides 
MYL2) were virtually absent in CMs seeded on crosslinked films without 
peptides or with VWFIIINIe, ratios could not be calculated meaningfully 
for these conditions. All other conditions yielded similar ratios, except 
for MYL2/MYL7 that was higher with GFOGER + VWFIIINle and GLO-
GEN + VWFIIINle. Additionally, we probed for calcium handling (RYR2 
and SERCA) and ion-channel (SCN5a) genes. Compared to crosslinked 
films with no peptide, all three were upregulated (20-fold for RYR2, 1.7- 
fold for SERCA and 2.5-fold for SCN5a in average) in the presence of 
integrin-binding THPs. VWFIIINle, however, did not contribute. Overall, 
CM gene expression demonstrate more advanced CM maturation in the 
presence of integrin-binding THPs. 
Calcium handling using Fluo-4 AM on cells paced at 1.5 Hz was then 
analysed (Fig. 5, A, Supporting videos). Time to peak (TTP; Fig. 5, B) and 
time to 90% decay (T90; Fig. 5, C) were measured to reflect the rapidity 
and synchronicity of CM response to electrical stimuli. Coordinated 
calcium release could not be observed on crosslinked films without 
peptides, defined peaks were poorly recorded, and the resulting pa-
rameters could not be calculated. In contrast, CMs contracted regularly 
(TTP 180.625 ± 5.694, T90 291 ± 30.759) on untreated collagen films. 
On crosslinked films, VWFIIINle, even if not always following the pacing, 
caused calcium release at regular spaced intervals. However, both TTP 
and T90 were significantly higher than on non-crosslinked films 
(253.375 ± 27.733 and 815.125 ± 310.078 respectively, p < 0.05). In 
contrast, GFOGER and GLOGEN, both prompted regular and synchron-
ised beating. Moreover, both TTP and T90 were comparable to the un-
treated control films with a small but significant decrease in the TTP 
with GLOGEN (TTP 164.125 ± 10.454 and 153.875 ± 13.263, p < 0.05; 
T90 315.625 ± 18.403 and 284.875 ± 16.226 respectively). Overall, 
integrin-binding THPs had a compelling positive impact on CM pheno-
type and behaviour, at least comparable to non-crosslinked collagen, 
while VWFIIINle had only a limited and non-significant effect. 
The effect of THPs in EC:CM co-cultures was investigated. Cells were 
seeded at a 10:1 ratio of CM:EC and cultured for 5 days. We first verified 
that both cell types survived and maintained their phenotype by CD31 
and Troponin-T staining (Fig. 6, A). Cell growth over 5 days and viability 
was assessed using PrestoBlue® (Fig. 6, B). Again, the overall cell 
Fig. 5. CM calcium release and CM contraction. hESC-derived CMs were cultured for 5 days at 37 ◦C with 5% CO2, loaded with Fluo-4AM and electrically paced at 
1.5 Hz. A) Transient calcium influx was assessed by measuring Fluo-4AM fluorescence intensity above background (F/F0) as a function of time in four independent 
repeats (n = 4). CMs seeded on non-crosslinked films and crosslinked films functionalized with GFOGER or GLOGEN showed regular and synchronised contractions. 
Time to peak (B) and Time to 90% decay (C) are plotted as mean ± s.e.m. Columns were compared to non-crosslinked films using Dunnett’s post-hoc test. GLOGEN 
significantly improved both time to peak and time to 90% decay while VWFIIINIe performed significantly worse (p < 0.05, Student’s t-test). Crosslinked films with no 
peptides are not shown as no defined peak to analyse were identifiable. 
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metabolic activity was dramatically affected by EDC/NHS crosslinking 
(dropping from 1.427 × 106 ± 27285 to 322667 ± 9838 AU) and could 
be restored by grafting GFOGER (1.43 × 106 ± 5774, p < 0.001), 
GLOGEN (1.91 × 106 ± 69282, p < 0.001), but also VWFIIINle (1.303 ×
106 ± 17638, p < 0.001). We hypothesized that although VWFIIINle does 
not affect CMs, it promotes EC activity and in turn has an effect in CM:EC 
co-culture. Moreover, GFOGER + VWFIIINle (1.975 × 106 ± 80978, p <
0.001) and GLOGEN + VWFIIINle (3.543 × 106 ± 145307, p < 0.001) 
had a stronger impact than each peptide grafted individually (p < 0.05). 
GLOGEN + VWFIIINle yielded best results, with significantly higher 
viability than on native collagen films (p < 0.01). 
Expression of CM maturation markers was re-evaluated in CMs 
cultured with ECs (Fig. 4) and compared to expression in CM only cul-
tures. CM gene expression was significantly increased on crosslinked 
films functionalized with THPs or on non-crosslinked films, compared to 
crosslinked films without peptides (1.15 × 104-fold for MYL7, 10-fold 
for MYL2, 7254-fold for MYH6, 5208-fold for MYH7, 1567-fold for 
TNNI1, 30-fold for TNNI3, 140-fold for RYR2, 13-fold for SERCA and 10- 
fold for SCN5a in average). Unlike in CM only cultures, VWFIIINle 
strongly upregulated gene expression, as importantly as GFOGER and 
GLOGEN. MYH7/MYH6, MYL2/MYL7 and TNNI3/TNNI1 ratios were 
calculated for all sets of THPs and followed the same pattern as on CM 
only cultures. VWFIIINle individually also augmented MYH7/MYH6, 
MYL2/MYL7 and TNNI3/TNNI1 ratios compared to CMs seeded on non- 
crosslinked films. Compared to CM only cultures, MYH7/MYH6 and 
TNNI3/TNNI1 but not MYL2/MYL7, values were higher, implying a 
more advanced CM maturation. Of note, in the co-cultures cardiac gene 
expression was consistently increased compared to the CM only cultures, 
in line with what has been previously reported [27]. 
Finally, the contractile ability of CMs in EC:CM co-cultures was 
evaluated (Fig. 7). Crosslinked films with no peptide still did not support 
CM beating. Non-crosslinked films supported coordinated beating but 
performed worse than with CM only cultures (TTP 186.229 ± 12.036, 
T90 432.71 ± 40.499). Contrary to CMs alone, in the presence of 
VWFIIINle cells contracted similarly as on the non-crosslinked controls 
(TTP 173.656 ± 13.486, T90 364.685 ± 55.596). A significant decreased 
in both TTP and T90 was observed with GFOGER (TTP 160.988 ± 4.908, 
T90 347.599 ± 35.263; p < 0.05), followed by GLOGEN (TTP 140.238 
± 6.251, T90 306.800 ± 25.428, p < 0.05) and GLOGEN + VWFIIINle 
(TTP 121.003 ± 6.820, T90 245.253 ± 27.024 p < 0.01). With GFOGER 
Fig. 6. Endothelial cells and cardiomyocytes 
co-cultures on crosslinked collagen films 
without peptide, functionalized with GFO-
GER, with GLOGEN, with VWFIIINle, with 
GFOGER þ VWFIIINle, with GLOGEN þ
VWFIIINle, or non-crosslinked films. A) CM:EC 
immunocytochemistry. hESC-derived ECs and 
CMs were cultured alongside for 5 days at 37 ◦C 
with 5% CO2 and stained with Troponin T (CM 
specific marker), CD31 (EC specific marker) and 
DAPI. Representative fields of view of merged 
fluorescence are shown. Scale bar 100 μm B) 
CM:EC viability. After 5 days at 37 ◦C with 5% 
CO2, PrestoBlue® was added to cell culture 
media, fluorescence at 560 nm was measured in 
three independent repeats (n = 3) and plotted as 
mean ± s.e.m. All sets of THPs significantly 
restored CM viability abolished by EDC/NHS 
treatment after 5 days (one-way ANOVA, p <
0.001). Columns were compared to crosslinked 
films with no peptides using Dunnett’s post-hoc 
test. GLOGEN + VWFIIINle resulted in signifi-
cantly higher cell viability than all other condi-
tions (Student’s t-test).   
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+ VWFIIINle however, only T90 was significantly shorter (TTP 152.378 
± 33.342, T90 299.553 ± 48.448 p < 0.05). GLOGEN associated with 
VWFIIINle was the best condition, with more rapid impulses, compared 
notably to both GLOGEN alone (p < 0.05) and native collagen. To 
further investigate the possible mechanism behind the synergistic effect 
observed on GLOGEN + VWFIIINle films, focal adhesion kinase (FAK) 
phosphorylation (p-FAK), was analysed by flow cytometry in endothe-
lial cells/cardiomyocytes co-culture. FAK is of relevance has it has been 
linked to cardiac contractility [28]. Supporting information 7 shows that 
in cardiomyocytes p-FAK levels are significantly higher on GLOGEN +
VWFIIINle films compared to Non-XL and GLOGEN only functionalized 
surfaces, confirming a similar trend to what was observed in Fig. 7 with 
the calcium transient analysis. 
3. Discussion 
Several models of engineered myocardium are being developed by 
considering different factors such as mechanical constraints [29] and 
electric stimulation [30]. Here, we instead aimed to employ specific and 
controlled interactions with the ECM, and in particular with collagen, to 
modulate ECs and CMs adhesion, proliferation and function. The most 
prevalent ECM proteins in the myocardium are collagen types I and III, 
in contact with CMs, and type IV, in contact with the basal lamina of ECs. 
Collagen is required for heart tissue organisation, resistance to me-
chanical workloads and plays a major role in EC organization [31] and 
CM contraction [32]. However, all the pathways involving 
collagen-binding proteins have yet to be determined, thus hindering the 
control of hESC-derived EC or CM fate on biomaterials. 
To elucidate these mechanisms and to fabricate active biomaterials, 
we utilized EDC/NHS-treated collagen films. EDC/NHS crosslinking is 
required to obtain stiff and stable materials, but drastically reduces 
recognition for crucial collagen-binding proteins, rendering the sub-
strate biologically inert. 
The influence of EDC/NHS treatment on collagen film mechanical 
properties has previously been investigated by our group. The cross-
linking method used in this work (with a 5:2:1 molar ratio of EDC:NHS: 
carboxylic acid moieties in collagen, referred to as 100% in our previous 
studies) raised the tensile Young’s modulus of 2D collagen films from 
5.7 MPa to 31 MPa [33]. This crosslinking is also necessary to ensure 
structural integrity of 3D collagen porous scaffolds, increasing their 
compressive modulus from 1.2 kPa to 6.2 kPa [15]. Since mechanical 
constraints play a central role in heart function and myocardial 
remodelling post-infarct, adequate mechanical properties obtained 
through EDC/NHS treatment are especially important for cardiac tissue 
engineering. A heart patch should provide a structural template for cell 
attachment and tissue formation that ideally matches the mechanical 
Fig. 7. CM:EC calcium release and contraction. hESC-derived CMs and ECs were cultured for 5 days at 37 ◦C with 5% CO2, loaded with Fluo-4AM and electrically 
paced at 1.5 Hz. A) Transient calcium influx was assessed by measuring Fluo-4AM fluorescence intensity above background (F/F0) as a function of time in three 
independent repeats (n = 3). Time to peak (B) and Time to 90% decay (C) are plotted as mean ± s.e.m. Columns were compared to non-crosslinked films using 
Dunnett’s post-hoc test. In the presence of endothelial cells, GLOGEN, GFOGER and GLOGEN + VWFIIINle significantly improved both time to peak and time to 90% 
decay while VWFIIINIe performed similarly to the control (p < 0.05, Student’s t-test). Crosslinked films with no peptides are not shown as no defined peak to analyse 
were identifiable. GLOGEN + VWFIIINle showed significant improvement also compared to GLOGEN alone (p < 0.05, Student’s t-test). 
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properties of the myocardium [34]. While a rigid but inelastic patch 
placed on the heart will impede contraction, a soft biomaterial will not 
be sufficiently resistant to withstand changes in strains in the native 
myocardium [35]. Moreover, the heart patch should not biodegrade 
before cardiac repair has been initiated. EDC/NHS crosslinking of 
collagen biomaterials thus constitutes a useful tool to achieve stable and 
resistant cardiac patches that can be used in regenerative medicine. 
Overall this methodology enabled us to tailor CM and EC interactions 
with collagen films and direct cell fate by grafting the correct set of THP 
ligands [36]. Despite their potential, THPs remain rarely used in tissue 
engineering [24,25,37–39]. In this study we aimed to determine the 
influence of collagen-binding protein recognition on hESC-derived CM 
and ECs cell response. 
First, we explored THPs’ influence on hESC-derived ECs. Cell 
spreading was significantly increased with GFOGER, GLOGEN and 
VWFIIINle compared to the control with no peptide. EC proliferation was 
enhanced with the addition of all THPs and consistent with previous 
results. THPs also improved Ac-LDL uptake in EC cytoplasm. Surpris-
ingly, on non-crosslinked films, where integrin binding sites are intact 
ECs did not spread and only few cells contained Ac-LDL. Non-crosslinked 
films may not be stable in cell culture media and might not provide a 
stable surface for ECs. Alternatively, collagen films, made from type I 
collagen, may not be the optimal surface for the ECs, naturally in contact 
with collagen type IV. Grafting collagen type I films with THPs saturates 
the surface with binding sites for integrins and VWFIIINle-binding pro-
teins, thus supplanting the need for collagen type IV binding sites. 
Overall, these results validate the positive impact of THP ligands on EC 
function. Due to VWFIIINle affinity for several collagen-binding proteins, 
it is difficult to distinguish through which pathway this peptide affects 
ECs. Nevertheless, mRNA expression in ECs suggests that SPARC would 
be the main partner for VWFIIINle [40,41]. 
CMs establish strong intercellular interactions that lead to sponta-
neous organized contraction. This was achieved by day 5 on non- 
crosslinked films or crosslinked films with integrin-binding peptides 
but not without peptides or with VWFIIINle where CMs formed clumps 
and were less viable. Proliferation studies corroborated further this 
observation. With clinical applications in mind, we aimed to produce 
substrates on which CM can proliferate to populate a biomaterial at high 
density highlighting the importance of functionalizing collagen-based 
constructs with the integrin-binding THPs. 
hESC-derived CMs are relatively immature, possess rudimentary 
sarcoplasmic reticulum and express fetal form of key sarcomeric pro-
teins [42]. We thus analysed expression of key genes associated with 
mature CMs. Compared to crosslinked films all genes were upregulated 
when interacting with GFOGER and GLOGEN, but not VWFIIINle. 
Integrin-binding THPs thus stimulated gene expression changes associ-
ated with CM maturation, reaching equivalent or higher levels than on 
native collagen. CM on crosslinked film underwent sparse and random 
contraction. Contrastingly, VWFIIINle prompted a regular calcium 
release but with significantly higher TTP and T90 compared to untreated 
collagen films. GFOGER or GLOGEN, however, restored synchronised 
beating to the pattern obtained on non-crosslinked films, highlighting 
once again the importance of the integrin-mediated interactions with 
collagen for the maturation, organization, and function of CMs. 
Unlike ECs, CMs are naturally in contact with collagen type I (along 
with type III) and consequently displayed viability, proliferation, 
maturation and coordinated beating on non-crosslinked films. These 
features are lost following EDC/NHS treatment, but were fully restored 
with the addition of integrin binding ligands, GFOGER or GLOGEN. 
VWFIIINle, however, only has a limited and often non-significant effect, 
despite CMs expressing genes coding for DDR1 and SPARC. Overall, both 
for ECs and CMs, GLOGEN had a slightly more important effect that 
GFOGER (both alone and in combination with VWFIIINle). Both cell lines 
express dramatically more α1β1 than other collagen-binding integrins. 
We attributed this difference in cellular response to GLOGEN higher 
affinity for α1β1 than GFOGER, thus sparking greater repercussions. 
Interactions between different cell types are pivotal for the assembly, 
organization and physiological role of tissues. We therefore performed 
co-cultures of CMs and ECs, as vascularization is a vital element for 
maintaining artificial tissues. As expected, the addition of THP ligands 
led to a significant improvement of cell growth. Interestingly, VWFIIINle 
alone also ameliorated cell viability as much as GFOGER. Moreover, cell 
viability was dramatically improved with GLOGEN in combination with 
VWFIIINle. 
Addition of THP ligands, including VWFIIINle alone, upregulated all 
the genes that were examined with identical patterns as in CM-only 
cultures. However, this upregulation was strikingly exacerbated in 
CM:EC co-cultures. This trend, confirmed by similarly greater MYH7/ 
MYH6 and TNNI3/TNNI1 ratios (but not MYL2/MYL7, higher with CMs 
only), indicates an advanced CM maturation when seeded alongside 
ECs. Finally, paced CM contraction was re-evaluated in co-cultures with 
ECs. Again, crosslinked films did not support any coordinated calcium 
release. Remarkably, in CM:EC co-culture VWFIIINle alone significantly 
improved calcium handling to levels equal to the non-crosslinked films. 
GFOGER and GFOGER with VWFIIINle lead to a decrease in both TTP and 
T90, although the addition of VWFIIINle did not lead to any additional 
beneficial effect. In comparison, a synergistic effect was observed with 
GLOGEN associated with VWFIIINle, which provided the best outcome 
with significantly faster calcium handling both compared to the un-
treated collagen films control and to GLOGEN alone. This synergistic 
effect was not observed with GFOGER leading to the hypothesis that 
GLOGEN exerts a slightly more pronounced effect due to its higher af-
finity for α1β1. This was confirmed in FAK phosphorylation experi-
ments, a key event in the integrin signalling pathway that has been 
previously linked to cardiac contractility [28]. When GLOGEN is used in 
combination with VWFIIINle, FAK phosphorylation is increased 
compared to the non-crosslinked films or GLOGEN-functionalized films, 
while this is not the case for GFOGER (Supporting information 7). These 
results reinforce both our observations that GLOGEN has a stronger ef-
fect than GFOGER, and that the association with VWFIIINle enhances the 
effect of GLOGEN. Of note, CMs with ECs on non-crosslinked films 
exhibited less acute impulses than with CMs alone. This may be 
explained by the lack of EC affinity for non-crosslinked films, leading to 
a detrimental impact on CM function. Overall, these results illustrate 
how a factor impacting on one cell type has repercussions on the global 
cell population. 
Our results demonstrate that CM and EC behaviour can be adjusted 
by functionalizing otherwise inert cell matrices with THP ligands for 
collagen-binding proteins. THP-functionalized crosslinked collagen 
biomaterials can thus be a novel and powerful tool for the design of an 
engineered myocardium with features that can be adapted by using 
different THPs. From a fundamental perspective, our study has 
contributed to assert the importance of collagen interactions with ECs 
and CMs on cell function. Having mechanical properties that match that 
of the human heart, functionalized collagen films can also constitute 
easy-to-use 2D platforms for in vitro assays and tissue engineering 
research. Our efforts are currently directed towards applying this tech-
nology to three-dimensional collagen-based scaffolds for the fabrication 
of patches for cardiac tissue repair that can operate as closely as possible 
to the native organ. 
4. Materials and methods 
4.1. General procedure for peptide synthesis 
9-Fluorenylmethoxycarbonyl (Fmoc) protected amino acids and N, 
N-Dimethylformamide (DMF) were supplied by AGTC Bioproducts 
(Hessle, UK). Fmoc-protected 6-Aminohexanoic acid (Ahx) was supplied 
by Merck (Darmstadt, Germany). All other amino acids and reagents 
were purchased from Sigma-Aldrich (Gillingham, UK). Peptides were 
synthesized as previously described [24,25]. Briefly, (GPP)5GFOGER 
(GPP)5, (GPP)5GLOGEN(GPP)5, Ahx-(GPP)5GPRGQOGVNleGFO(GPP)5 
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and GPC(GPP)10GPC (GPP10) were synthesized as C-terminal amides on 
Rink amide aminomethyl Tantagel resin (0.526 g, loading 0.19 mmol. 
g-1, RAPP Polymere) by Fmoc/tert-butyl solid phase strategy. Peptide 
GFGEEG was synthesized as C-terminal acid on Fmoc-Gly-Wang (0.127 
g, 0.79 mmol g− 1, Novabiochem). N-terminal end-stapling of three 
peptide strands of (GPP)5GFOGER(GPP)5 (GPP),5GLOGEN(GPP)5 and 
Ahx-(GPP)5GPRGQOGVNleGFO(GPP)5 (5.10–5 mol) was performed on 
solid support by reaction with Fmoc-GFEEG-OH (4.5 mg, 5.6.10–6 mol) 
followed by Fmoc deprotection in DMF with 20% piperidine for 2 × 15 
min. DIEA (5.7 μl, 3.3.10–5 mol) and NHS-Diazirine (5.63 mg, 2.5.10–5 
mol, Life Technologies) were dissolved in DMF and added to resin beads 
(8.3.10–6 mol) in the dark overnight to give Diazirine-coupled end--
stapled (GPP)5GFOGER(GPP)5 (denoted GFOGER), (GPP)5GLOGEN 
(GPP)5 (denoted GLOGEN) and Ahx-(GPP)5GPRGQOGVNleGFO(GPP)5 
(denoted VWFIIINle). Cleavage from the resin was performed in a 
mixture of trifluoroacetic acid (TFA)/triisopropylsilane (TIS)/H2O 
95/2.5/2.5 v/v/v for 2h. The cleavage solution was concentrated and 
precipitated in 20 ml of cold diethyl ether. The white precipitate was 
filtered, washed with 10 ml of cold diethyl ether, dissolved in a 
H2O/acetonitrile (ACN) 95/5 v/v (0.1% TFA) and freeze dried. The 
crude product was purified by preparative reverse-phase high perfor-
mance liquid chromatography (RP-HPLC) on a PerkinElmer LC200 
system equipped with a 10 μm Eurospher II 100-10C18H (Knauer, 
Berlin, Germany). Purified compounds were characterized by 
matrix-assisted laser desorption ionization time-of-flight mass spec-
trometry at the Protein and Nucleic Chemistry Facility (University of 
Cambridge, UK, Supporting information 8). Peptide purity and transi-
tion temperature was assessed via polarimetry as previously described 
[24]. Briefly, peptides were solubilized in 900 μl of 10 mM phosphate 
buffer with 150 mM NaCl at 2 mg/ml, heated to 70 ◦C for 10 min and left 
at 4 ◦C overnight. Peptide solutions were heated from 8 ◦C to 80 ◦C at a 
ramp-rate of 1 ◦C/min in an Autopol III polarimeter and the optical 
rotation was plotted against the temperature (Supporting information 
9). 
4.2. EDC/NHS crosslinking and THP-functionalization of collagen films 
Collagen films were prepared as previously described in Grover et al. 
[16,24]. Briefly, bovine Achilles tendon collagen type I (Sigma, #4387, 
Gillingham, UK) was suspended in 0.05 M AcOH at a concentration of 
0.5% w/v and left to swell overnight at 4 ◦C. The mixture was homog-
enized using an Ultra-Turrax VD125 blender for 20 min at 13500 rpm, 
centrifuged 5 min at 2500 rpm, homogenized 10 min at 13500 rpm and 
centrifuged 5 min at 2500 rpm. The resulting slurry was left overnight at 
room temperature before use. 96-well or 12-well plates were coated 
with respectively 100 μl or 400 μl of slurry and left to dry for three days 
in a fume hood. Film crosslinking was performed using of a mixture of 
1.115 g EDC and 0.276 g NHS per gram of collagen in 75% EtOH for 2h 
at room temperature (referred to as 100% crosslinking in our previous 
work). Wells were washed with EtOH 3 × 10 min and deionized water 
three times for 10 min and left to dry for three days in a fume hood. 
Photoreactive peptides and GPP10 were diluted to 2.5 μg/ml in PBS (pH 
7.4) from a 5 mg/ml stock solution in 0.01 M AcOH. 100 μl on 96-well 
plates or 400 μl on 12-well plates of peptide solution were added to 
collagen films and incubated for 30 min in the dark at room tempera-
ture. Collagen films were then placed under a long-wavelength UV lamp 
(Blak-Ray B100AP, 365 nm wavelength) for 5 min and washed with 
citrate buffer (pH 3) 6 × 2 min and PBS 6 × 2 min. 
4.3. Cell line generation and culture conditions 
H9 hESCs were maintained as colonies as described in Iyer et al. [43]. 
Endothelial cells. ECs were differentiated adapting a protocol from 
Patsch et al. [44]. 70% confluent H9 hESCs were split as colonies into a 
10 cm2 cell culture dishes one day prior to protocol initiation. On Day 0, 
H9-hESC media was aspirated, the dish washed with PBS, and replaced 
with 6 ml of CDM-PVA containing FGF-2 (20 ng/ml), LY294002 (10 μM) 
and BMP-4 (10 ng/ml). After 36 h, media was replaced with 
STEMPRO-34 SFM (Life technologies) containing VEGF-A (200 ng/ml, 
Peprotech), Forskolin (TOCRIS, 2uM) and Ascorbic Acid (100 mM, 
Sigma). After 24 h the media was refreshed, and the plate stored for a 
further 2 to 3 days before magnetic sorting using CD34 conjugated 
magnetic microbeads (Miltenyi Biotech) according to the manufac-
turer’s instructions. The positively selected cells were then cultured on 
gelatin coated plates in STEMPRO-34 SFM supplemented with VEGF-A 
(50 ng/ml) and FGF-2 (8 ng/ml). Media was refreshed every 48 h 
until seeding, with cells split up to a maximum of 4 passages. Prior to 
use, 70–90% confluent ECs cultured in 6-well plates were washed with 
PBS and detached with 300 μl TrypLE for 5 min at 37 ◦C. TrypLE was 
quenched with 1 ml of PBS and cells were spun down at 12000 rpm for 4 
min. Cells were re-suspended in EGM-2 and 500 μl of cell solution were 
added on collagen films prepared on 96- or 12-well plates. 
Cardiomyocytes. H9 hESCs were differentiated to cardiomyocyte 
using the protocol adapted from Mendjan et al. [45]. Briefly, H9 hESCs 
were seeded at a density of 105 cells/cm2 in a 12 well plate coated with 
Matrigel (Corning) in CDM-BSA supplemented with ROCK inhibitor 
(Millipore, 1 μm). Media was changed after 3 h to CMD-BSA, supple-
mented with FGF-2 (20 ng/ml), Activin-A (50 ng/ml), BMP-4 (10 ng/ml, 
R&D) and LY294002 (10 μM Tocris). After 42 h media was changed to 
CDM-BSA supplemented with FGF-2 (8 ng/ml), BMP4 (20 ng/ml), Ret-
inoic Acid (SIMGA, 1 μM), endo-IWRI (1 μM, TOCRIS). Cells were 
maintained with this media for 4 days with media refreshed every 48 h. 
Media was changed to CDM-BSA supplemented with FGF-2 (8 ng/ml), 
BMP4 (20 ng/ml) for an additional 2 days. Media was then changed to 
CDM-BSA with no cytokines and replaced every 48 h. Spontaneous 
beating is generally observed 8–10 days after seeding. 
4.4. RNA extraction, retrotranscription and RT-qPCR 
RNA was extracted using GenElute™ Mammalian Total RNA Mini-
prep Kit (Sigma) according to the manufacturer’s instructions. 250 ng of 
RNA was subsequently retrotranscribed to complementary DNA (cDNA) 
using Maxima First Strand cDNA Synthesis Kit (Thermo scientific). For 
CM cardiac genes and collagen-binding integrins, RT-qPCR was per-
formed using Fast SYBR® Green Master Mix on a 7500 Real-Time PCR 
System using GAPDH as housekeeping gene. All primers for CM cardiac 
genes (listed in the table below) were designed to span an intron-exon 
junction. For VWFIIINle-binding proteins, RT-qPCR was performed 
using Taqman primers and Taqman Gene expression Mastermix reagents 
(Thermo Fisher) on a 7300 Real-Time PCR System using HPRT1 as 
housekeeping gene. mRNA relative expression was obtained using the 
ΔCt method.  
Gene Fw primer Rev primer 
hGAPDH AACAGCCTCAAGATCATCAGC GGATGATGTTCTGGAGAGCC 
MYH7 ACTGCCGAGACCGAGTATG GCGATCCTTGAGGTTGTAGAGC 
MYH6 GCCCTTTGACATTCGCACTG GGTTTCAGCAATGACCTTGCC 
TNNI1 CCGGAAGTCGAGAGAAAACCC TCAATGTCGTATCGCTCCTCA 
TNNI3 TTTGACCTTCGAGGCAAGTTT CCCGGTTTTCCTTCTCGGTG 
SCN5A GAGCTCTGTCACGATTTGAGG GAAGATGAGGCAGACGAGGA 
RYR2 ACAACAGAAGCTATGCTTGGC GAGGAGTGTTCGATGACCACC 
SERCA ACAATGGCGCTCTCTGTTCT ATCCTCAGCAAGGACTGGTTT 
MYL2 TACGTTCGGGAAATGCTGAC TTCTCCGTGGGTGATGATG 
MYL7 CCGTCTTCCTCACGCTCTT TGAACTCATCCTTGTTCACCAC  
4.5. Cell adhesion 
96-well plates were coated with crosslinked collagen films func-
tionalized with GFOGER, GLOGEN or VWFIIINle as described above, or 
with GPP10 at 10 μg/ml overnight. 100 μl of a suspension of ECs at 5 ×
105 cells/ml in sterile PBS containing 5 mM Mg2+ were added to wells. 
Cells were incubated at 37 ◦C for 20 min and were washed gently with 
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200 μl of PBS three times. 150 μl of lysis buffer (containing 21 mg/ml 
disodium citrate, 6 mg/ml citric acid, 0.1% Triton X-100 and 5 mM p- 
nitrophenyl phosphate) were added for 90 min at room temperature. 
The reaction was terminated with 50 μl of 2 M sodium hydroxide and 
absorbance at 405 nm was measured [46]. 
4.6. Cell spreading 
500 μl of ECs at 5.104 cells/ml in STEMPRO-34 SFM were added on 
collagen films prepared on 12-well plates. Cells were incubated at 37 ◦C 
with 5% CO2 for 45 min, fixed with 3% paraformaldehyde for 15 min 
and washed three times with 1% BSA in PBS. Cells were permeabilized 
by adding 500 μl of 0.5% Triton X-100 for 5 min, then stained with 500 
μl of Rhodamine-Phalloidin (0.2 U/ml in PBS containing 0.1% BSA) 
during 45 min. Mean cell size were measured by locating rhodamine 
fluorescence on 10 randomly selected fields of view acquired on a Leica 
DM6000 FS fluorescence microscope using identical microscope settings 
between experiments. Representative fields of view shown in Fig. 2 were 
acquired on an Olympus FV300 laser-scanning confocal microscope. 
4.7. Cell proliferation 
For endothelial cells. 500 μl of ECs at 5.104 cells/ml in STEMPRO-34 
SFM were added to collagen films prepared on 12-well plates. Cells 
were incubated for 24 h at 37 ◦C with 5% CO2. 20 μl per well of EdU (5- 
ethynyl-2′-deoxyuridine, Thermo Fisher) at 1 mM was added and cells 
were incubated for a further 2h at 37 ◦C with 5% CO2 in the dark. Cells 
were fixed with 3% paraformaldehyde for 15 min, washed three times 
with 500 μl of 3% BSA in PBS, permeabilized with 1 ml of 0.5% Triton X- 
100 in PBS for 10 min and washed twice with 500 μl of 3% BSA in PBS. 
500 μl per well of Click-iT solution (Thermo Fisher), together with 
1:2000 of Hoechst 33342 stain, were added for 30 min in the dark and 
washed three times with PBS. Percentage of proliferating cells was 
calculated as the ratio of cell nuclei stained with Alexa-Fluor 488 over 
nuclei stained with Hoechst 33342 in 10 randomly selected fields of 
view for each condition acquired on a Leica DM6000 FS fluorescence 
microscope in three repeats. 
For cardiomyocytes. Collagen films were washed once with PBS and 
pre-conditioned with cell culture media for 1 h before cell seeding. 
Cardiomyocytes were dissociated using TrypLE (Life technologies) and 
plated at a concentration of 105 cells per film in a 96-well plate, in CDM 
BSA supplemented with ROCK inhibitor 1μM. 10 μM per well BrdU 
dissolved in culture medium was added and incubated for 12 h before 
fixing the cells in 4% paraformaldehyde (PFA). After washing with PBS, 
cells were incubated in 1.5 M HCl for 30 min (Antigen retrieval step), 
washed and incubated overnight at 4 ◦C mouse anti-BrdU (1:50 Becton- 
Dickinson, Ref: 347580) in 3% BSA/0.5%Triton-X-100 in PBS overnight 
at 4 ◦C. Alexa-Fluor 568 Rabbit anti-mouse (Life Technologies Ref: 
A11061) diluted 1:400 in 3% BSA/0.5%Triton-X-100 in PBS was added 
and samples were incubated at room temperature for 1 h on a rocker, 
washed in PBS and incubated with DAPI (Sigma, 1 μg/ml) for 5 min at 
room temperature. Percentage of proliferating cells was calculated as 
the ratio of cell nuclei stained with Alexa-Fluor 568 over nuclei stained 
with DAPI in 5 randomly selected fields of view for each condition ac-
quired on a Zeiss Axiovert inverted microscope in three independent 
repeats. 
4.8. LDL uptake 
70–90% confluent ECs were starved with EBM with 0.05% FBS for 
2h. Cells were then washed with PBS and detached with 300 μl TrypLE 
for 5 min at 37 ◦C. TrypLE was cancelled with 1 ml of PBS and cells were 
spun down at 12000 rpm for 4 min. Cells were re-suspended in 
STEMPRO-34 SFM at 5.104 cells/ml with 0.5 μl/ml of 1,1′-Dioctadecyl- 
3,3,3′,3′-Tetramethyl-indo-carbocyanine perchlorate (DiI) conjugated 
acetylated Low Density Lipoprotein (Ac-LDL) and 500 μl were added on 
collagen films prepared on 12-well plates. Cells were incubated for 24 h 
at 37 ◦C with 5% CO2, fixed with 3% paraformaldehyde for 15 min, 
washed three times with 3% BSA in PBS, permeabilized with 0.5% 
Triton X-100 in PBS for 10 min and washed twice with 3% BSA in PBS. 
Cell nuclei were stained with 1:2000 Hoechst 33342 in PBS for 30 min in 
the dark and washed three times with PBS. Ac-LDL-Dil fluorescence were 
measured and Hoechst-stained cells were counted in 10 randomly 
selected fields of view for each condition in four repeats on a Leica 
DM6000 FS or Zeiss Axio Z1 fluorescence microscope. 
4.9. Immunocytochemistry and flow cytometry 
Collagen films were washed once with PBS and pre-conditioned with 
cell culture media for 1 h before cell seeding. Cardiomyocytes were 
dissociated using TrypLE (Life technologies) and plated at a concentra-
tion of 105 cells per film in a 96-well plate in CDM BSA supplemented 
with ROCK inhibitor 1 μM. For co-cultures, endothelial cells were coated 
alongside at a ratio of endothelial cells to cardiomyocyte of 1:10 in 
STEMPRO-34 supplemented with VEGF-A (50 ng/ml). Cells were fixed 
with 4% PFA, permeabilized with 0.1% Triton (Sigma) in PBS for 15 min 
before blocking with 3% BSA (Sigma) in PBS for 1 h and overnight in-
cubation with primary antibody (diluted accordingly). Cells were then 
washed in PBS and incubated with the appropriate secondary antibody 
for 2 h at room temperature, washed and stained with DAPI (Sigma, 1 
μg/ml) before imaging on an Axiovert inverted microscope (Zeiss). 
Primary (I) and secondary (II) antibodies are listed in the table below. 
Flow cytometry was performed using BD Cytofix/Cytoperm kit (BD 
biosciences, cat. 554714) according to the manufacturer instruction. 
Data were acquired on LSRFortessa (BD bioscience) flow cytometer and 
analysed using FlowJo VX software version 9.9.4.  
Antibody Supplier Cat. Number 
Goat polyclonal anti Cardiac Troponin T (I) Abcam ab64623 
Rabbit polyclonal anti CD31 (I) Novus biologicals NB100-2284 
Mouse monoclonal Anti-BrdU antibody (I) Sigma B8434 
Mouse monoclonat Anti-Connexin-43 (I) Millipore MAB3067 
Donkey anti Rabbit Alexa 488 (II) Life Technologies R37118 
Donkey anti goat Alexa 568 (II) Life Technologies A-11057 
Donkey anti goat Alexa 488 (II) Life Technologies A-11055 
Chicken anti-mouse 488 (II) Life Technologies A-21200 
Donkey anti-mouse 568 (II) Life Technologies A10037 
Donkey anti-rabbit 647 (II) Life Technologies A32795 
Mouse anti VECAD-APC Miltenyi Biotec 130-125-985 
Alexa Fluor® 488 Mouse anti-FAK (pS910) BD bioscience 558544 
Mouse anti CD29 -APC Miltenyi Biotec 130-101-280 
Mouse anti CD49a - APC Miltenyi Biotec 130-101-395 
REAfinity anti CD49b - APC Miltenyi Biotec 130-100-337 
Rabbit anti ITGA10 ThermoFisher PA5-100840 
Rabbit anti ITGa11 Biorbyt 184286 
Mouse IgG control -FITC Biolegend 400108 
Mouse IgG control - APC Biolegend 981806  
4.10. Cell viability 
Collagen films were washed once with PBS and pre-conditioned with 
cell culture media for 1 h before cell seeding. Cardiomyocytes were 
dissociated using TrypLE (Life technologies) and plated at 105 cells per 
film in CDM BSA supplemented with ROCK inhibitor 1 μM. For co- 
cultures, endothelial cells were coated alongside at a ratio of endothe-
lial cells to cardiomyocyte of 1:10 in STEMPRO-34 supplemented with 
VEGF-A (50 ng/ml). PrestoBlue® Cell Viability Reagent (Thermo Sci-
entific) was added to culture media according to the manufacturer’s 
instructions. Cells were incubated with the dye for 2 h. Media was then 
sampled and fluorescence at 560 nm analysed using VICTOR Multilabel 
Plate Reader (PerkinElmer). Media containing PrestoBlue® incubated in 
empty wells was used as background control. 
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4.11. Fluo-4 AM calcium analysis 
Collagen films were washed once with PBS and pre-conditioned with 
cell culture media for 1 h before cell seeding. Cardiomyocytes were 
dissociated using TrypLE (Life technologies) and plated at 105 cells per 
film in CDM BSA supplemented with ROCK inhibitor 1 μM. For co- 
cultures, endothelial cells were coated alongside at a ratio of endothe-
lial cells to cardiomyocyte of 1:10 in STEMPRO-34 supplemented with 
VEGF-A (50 ng/ml). Fluo-4 AM (Life technologies) was added to the cell 
culture media for 30 min at 37 ◦C. Cells were paced at a frequency of 1.5 
Hz using an EDP 30B dual chamber pacer (Biotronix). Videos were 
recorded on an Axiovert inverted microscope (Zeiss) using a Sony 
LEGRIA camera. Videos were then analysed with FIJI ImageJ software 
and using Time Series analyser V3 Plug in. Time to peak and time to 90% 
decay were calculated using Matlab R2019b. 
4.12. Statistical analysis 
Values shown are mean ± standard error of the mean (s.e.m.), from 
three or four biologically independent experiments. Mean values were 
compared using Prism software (GraphPad, San Diego) and 1-way 
ANOVA or 2-way ANOVA with Dunnett’s post-tests, comparing all 
conditions to crosslinked films with no peptide. Legend **** on figure 
denotes p < 0.0001, *** denotes p < 0.001, ** denotes p < 0.01, * de-
notes p < 0.05 and ns denotes non-significant. Comparisons between 
other pairs of columns were performed using Student’s t-test. 
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